Columbia Sportswear (COLM) 10-Q 7 May 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2020	Apr. 24, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	000-23939
Entity Registrant Name	COLUMBIA SPORTSWEAR COMPANY
Entity Incorporation, State or Country Code	OR
Entity Tax Identification Number	93-0498284
Entity Address, Address Line One	14375 Northwest Science Park Drive
Entity Address, City or Town	Portland
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97229
City Area Code	503
Local Phone Number	985-4000
Title of 12(b) Security	Common stock
Trading Symbol	COLM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		66,119,051
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001050797
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Operating Lease, Liability, Noncurrent	$ 364,300	$ 371,507	$ 337,832
Current Assets:
Cash and cash equivalents	671,108	686,009	430,447
Short-term investments	35,828	1,668	272,603
Accounts receivable, net of allowance of $6,887, $9,043 and $8,666, respectively	312,951	488,233	341,136
Inventories	577,124	605,968	520,614
Prepaid expenses and other current assets	113,726	93,868	73,850
Total current assets	1,710,737	1,875,746	1,638,650
Property, plant and equipment, at cost, net of accumulated depreciation of $472,447, $455,811 and $435,625, respectively	332,997	346,651	298,379
Operating Lease, Right-of-Use Asset	387,984	394,501	362,568
Intangible assets, net (Note 5)	122,850	123,595	125,830
Goodwill	68,594	68,594	68,594
Deferred Income Tax Assets, Net	73,827	78,849	77,760
Other non-current assets	54,498	43,655	41,928
Total assets	2,751,487	2,931,591	2,613,709
Current Liabilities:
Line of Credit, Current	174,443	0	0
Accounts payable	150,971	255,372	186,943
Accrued liabilities (Note 6)	214,044	295,723	224,385
Operating Lease, Liability, Current	64,456	64,019	59,214
Income taxes payable	6,441	15,801	9,302
Total current liabilities	610,355	630,915	479,844
Operating Lease, Liability, Noncurrent	364,300	371,507	337,832
Income taxes payable, noncurrent	48,320	48,427	50,610
Deferred Income Tax Liabilities, Net	8,944	6,361	9,112
Other Liabilities, Noncurrent	22,977	24,934	15,662
Total liabilities	1,054,896	1,082,144	893,060
Commitments and Contingencies
Equity:
Preferred stock; 10,000 shares authorized; none issued and outstanding	0	0	0
Common stock (no par value); 250,000 shares authorized; 69,988, 69,995, and 69,686 issued and outstanding, respectively (Note 9)	565	4,937	94
Retained earnings	1,704,000	1,848,935	1,723,873
Accumulated other comprehensive loss (Note 8)	(7,974)	(4,425)	(3,318)
Total shareholders' equity	1,696,591	1,849,447	1,720,649
Total liabilities and equity	$ 2,751,487	$ 2,931,591	$ 2,613,709

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 27,579	$ 8,925	$ 8,388
Accumulated depreciation for property, plant and equipment	$ 530,329	$ 523,092	$ 500,018
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Common stock, no par value (in dollars per share)	$ 0	$ 0	$ 0
Common stock, shares authorized (in shares)	250,000,000	250,000,000	250,000,000
Common Stock, Shares, Issued	66,116,000	67,561,000	68,346,000
Common Stock, Shares, Outstanding	66,116,000	67,561,000	68,346,000

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales	$ 568,228	$ 654,608
Cost of sales	296,514	317,879
Gross profit	271,714	336,729
Selling, general and administrative expenses	276,820	251,755
Other Operating Income (Expense), Net	3,119	2,984
Income from operations	(1,987)	87,958
Interest income, net	1,813	3,400
Other non-operating expense	1,738	446
Income (Loss) Attributable to Parent, before Tax, Total	1,564	91,804
Income tax expense	(1,351)	(17,627)
Net income attributable to Columbia Sportswear Company	$ 213	$ 74,177
Earnings per share (Note 9):
Basic (in dollars per share)	$ 0	$ 1.09
Diluted (in dollars per share)	$ 0	$ 1.07
Weighted average shares outstanding (Note 9):
Basic (in shares)	66,970	68,290
Diluted (in shares)	67,412	69,052

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net Income (Loss) Attributable to Parent	$ 213	$ 74,177
Other comprehensive income:
Unrealized holding gains on available-for-sale securities, net		56
Unrealized gains on derivative transactions (net of tax effects of $(4,145) and $(395), respectively)	11,525	1,333
Foreign currency translation adjustments (net of tax effects of $497 and $663, respectively)	(15,074)	(545)
Other comprehensive income	(3,549)	844
Comprehensive income attributable to Columbia Sportswear Company	(3,336)	75,021
AOCI Attributable to Parent [Member]
Other comprehensive income:
Unrealized holding gains on available-for-sale securities, net	0	56
Unrealized gains on derivative transactions (net of tax effects of $(4,145) and $(395), respectively)	11,525
Foreign currency translation adjustments (net of tax effects of $497 and $663, respectively)	$ (15,074)	$ (545)

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Unrealized losses on derivative transactions tax effects	$ 4,145	$ 395
Foreign currency translation adjustments tax effects	$ (497)	$ (663)

Condensed Consolidated Statem_4

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Payments to Noncontrolling Interests	$ 0	$ (13,970)
Cash flows from operating activities:
Net income	213	74,177
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	32,994	28,998
Provision for Other Losses	19,229	(2,317)
Loss on disposal of property, plant, and equipment	2,138	958
Deferred income taxes	3,802	191
Stock-based compensation	3,675	4,215
Changes in operating assets and liabilities:
Accounts receivable	150,687	110,954
Inventories	23,510	862
Prepaid expenses and other current assets	(11,922)	6,952
Other assets	(5,873)	(3,394)
Accounts payable	(100,402)	(81,242)
Accrued liabilities	(77,861)	(54,723)
Income taxes payable	(9,429)	(13,761)
Increase (Decrease) In Operating Lease Assets And Liabilities	(16,807)	(14,721)
Other liabilities	(1,200)	1,495
Net cash provided by operating activities	12,754	58,644
Cash flows from investing activities:
Purchases of short-term investments	(35,044)	(136,257)
Proceeds from Sale, Maturity and Collection of Short-term Investments	1,631	128,000
Capital expenditures	(9,452)	(25,199)
Net cash used in investing activities	(42,865)	(33,456)
Cash flows from financing activities:
Proceeds from credit facilities	175,719	21,942
Repayments on credit facilities	(1,054)	(21,942)
Proceeds from issuance of common stock under employee stock plans	1,096	8,579
Tax payments related to restricted stock unit issuances	(4,207)	(5,432)
Payments for Repurchase of Common Stock	(132,889)	(18,845)
Payments to Noncontrolling Interests	0	13,970
Cash dividends paid	(17,195)	(16,418)
Net cash used in financing activities	21,470	(46,086)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(6,260)	(450)
Net increase (decrease) in cash and cash equivalents	(14,901)	(21,348)
Cash, cash equivalents and restricted cash, beginning of period	686,009	451,795
Cash, cash equivalents and restricted cash, end of period	671,108	430,447
Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes	19,953	31,646
Supplemental disclosures of non-cash investing activities:
Capital expenditures incurred but not yet paid	$ 2,503	$ 8,177

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Equity Parenthetical - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Common Stock, Dividends, Per Share, Cash Paid	$ 0.26	$ 0.24

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Equity Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Non-controlling Interest [Member]
Common Stock, Shares, Outstanding		68,246
Stockholders' Equity Attributable to Parent		$ 0	$ 1,677,920	$ (4,063)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,690,313
Stockholders' Equity Attributable to Noncontrolling Interest					$ 16,456
Net income	74,177		74,177
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	16,555			99	16,456
Unrealized holding gains on available-for-sale securities, net	56			56
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	1,333
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	1,333			1,333
Foreign currency translation adjustments (net of tax effects of $497 and $663, respectively)	(545)			(545)
Dividends, Cash	(16,418)		(16,418)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		296
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	3,147	$ 3,147
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	4,215	$ 4,215
Stock Repurchased During Period, Shares		(196)
Stock Repurchased During Period, Value	$ (19,074)	$ (7,268)	(11,806)
Common Stock, Shares, Outstanding	68,346	68,346
Stockholders' Equity Attributable to Parent	$ 1,720,649	$ 94	1,723,873	(3,318)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,720,649
Stockholders' Equity Attributable to Noncontrolling Interest					$ 0
Common Stock, Shares, Outstanding	67,561	67,561
Stockholders' Equity Attributable to Parent	$ 1,849,447	$ 4,937	1,848,935	(4,425)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,849,447
Net income	213		213
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests				99
Unrealized holding gains on available-for-sale securities, net				0
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	11,525			11,525
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	11,525
Foreign currency translation adjustments (net of tax effects of $497 and $663, respectively)	(15,074)			(15,074)
Dividends, Cash	(17,195)		(17,195)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		112
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(3,111)	$ (3,111)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	3,675	$ 3,675
Stock Repurchased During Period, Shares		(1,557)
Stock Repurchased During Period, Value	$ (132,889)	$ (4,936)	(127,953)
Common Stock, Shares, Outstanding	66,116	66,116
Stockholders' Equity Attributable to Parent	$ 1,696,591
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,696,591	$ 565	$ 1,704,000	$ (7,974)

Basis Of Presentation And Organ

Basis Of Presentation And Organization	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Organization	The accompanying unaudited condensed consolidated financial statements have been prepared by the management of Columbia Sportswear Company (together with its wholly owned subsidiaries, the "Company") and, in the opinion of management, include all normal recurring material adjustments necessary to present fairly the Company's financial position as of March 31, 2020, December 31, 2019 and March 31, 2019, and the results of operations for the three months ended March 31, 2020 and 2019, and cash flows for the three months ended March 31, 2020 and 2019. The December 31, 2019 financial information was derived from the Company's audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. A significant part of the Company's business is of a seasonal nature; therefore, results of operations for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for other quarterly periods or for the full year. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company, however, believes that the disclosures contained in this report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, for a Quarterly Report on Form 10-Q and are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. Principles of Consolidation The condensed consolidated financial statements include the accounts of Columbia Sportswear Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates and assumptions. Some of the more significant estimates relate to revenue recognition, allowance for uncollectible accounts receivable, excess, close-out and slow moving inventory, product warranty, impairment of long-lived assets, intangible assets and goodwill, income taxes, and stock-based compensation. A novel strain of coronavirus ("COVID-19") was first identified in China in December 2019 and a global pandemic of respiratory disease caused by COVID-19 was declared by the World Health Organization in March 2020. As of March 31, 2020, in response to this pandemic, many governments worldwide had implemented travel restrictions, business shutdowns or slowdowns, and shelter-in-place or stay-at-home orders. In first quarter 2020, lower consumer demand related to the COVID-19 pandemic began to impact the Company's financial performance in China in late January, Korea and Japan in early February and North America and Europe in March. Retail traffic trends declined across North America and Europe in early March, prior to store closures which began in mid-March. As of the date of this filing, certain regional and local governments have lifted restrictions and orders. The current environment of uncertainty significantly affected the March 31, 2020 estimates for allowance for uncollectible accounts receivable and excess, close-out and slow-moving inventory. These estimates involve assumptions about future events. The allowance for uncollectible accounts receivable includes assumptions about the future financial condition of our customers and their ability to make required payments. The provision for excess, close-out and slow moving inventory includes assumptions about future demand for the Company’s products and the Company's ability to sell them at a profit. As a result of lower consumer demand related to the COVID-19 pandemic, we tested certain retail locations and their respective lease right-of-use assets for impairment. While no significant impairments were identified, further declines in projected future performance or significant declines in market rents for retail spaces may adversely affect the recovery of these retail locations assets. Additionally, as a result of the COVID-19 pandemic and a significant decline in projected net sales, the prAna brand's trademark and goodwill were tested for impairment as of March 31, 2020. While no impairment was indicated during the first quarter 2020 tests, the degree by which the fair value of the prAna reporting unit and trademark exceeded their respective carrying values declined from our 2019 impairment test. If, due to the current level of uncertainty relating to the COVID-19 pandemic, the prAna brand's actual or projected future performance deteriorates from the projections considered in our first quarter 2020 impairment tests, it is possible that an impairment charge would be required. Recently Adopted Accounting Pronouncements Effective January 1, 2020, the Company adopted Accounting Standards Update ("ASU") No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) issued by the Financial Accounting Standards Board ("FASB") in August 2018, which clarifies certain aspects of accounting for implementation costs incurred in a cloud computing arrangement ("CCA") that is a service contract. Under the ASU, an entity would expense costs incurred in the preliminary-project and post-implementation-operation stages. The entity would also capitalize certain costs incurred during the application-development stage, as well as certain costs related to enhancements. The ASU does not change the accounting for the service component of a CCA. The Company adopted the standard using the prospective method and anticipates an increase in cloud-specific implementation assets as specific cloud initiatives are executed by the Company. These assets will generally be included in Other non-current assets in the Condensed Consolidated Balance Sheets and will amortize over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. Upon the adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. Effective January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment issued by the FASB in January 2017, which simplifies the accounting for goodwill impairments by eliminating step two from the goodwill impairment test. Under this guidance, if the carrying amount of a reporting unit exceeds its estimated fair value, an impairment charge shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The impact of the new standard will depend on the specific facts and circumstances of future individual goodwill impairments, if any. Effective January 1, 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments issued by the FASB in June 2016, as well as the clarifying amendments subsequently issued. The pronouncement changes the impairment model for most financial assets and will require the use of an "expected loss" model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Upon adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. On an ongoing basis, the Company will contemplate forward-looking economic conditions in recording lifetime expected credit losses for the Company’s financial assets measured at cost, such as the Company’s trade receivables and certain short-term investments. The following significant accounting policy has been updated since the Company’s 2019 Annual Report on Form 10-K as a result of adoption of ASU No.2016-13: Accounts Receivable Accounts receivable have been reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability of the Company's customers to make required payments. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations. Write-off activity and recoveries for the periods presented were not material. Recent Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU No. 2019-12 ,

Revenues

Revenues	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenues	Disaggregated Revenue As disclosed below in Note 12, the Company has four geographic reportable segments: United States ("U.S."), Latin America and Asia Pacific ("LAAP"), Europe, Middle East and Africa ("EMEA"), and Canada. The following tables disaggregate the Company's operating segment Net sales by product category and sales channel, which the Company believes provide a meaningful depiction of how the nature, timing, and uncertainty of Net sales are affected by economic factors: Three Months Ended March 31, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 309,677 $ 75,913 $ 39,930 $ 26,649 $ 452,169 Footwear 66,191 26,738 15,918 7,212 116,059 Total $ 375,868 $ 102,651 $ 55,848 $ 33,861 $ 568,228 Sales channel net sales Wholesale $ 202,868 $ 57,374 $ 42,256 $ 23,462 $ 325,960 Direct-to-consumer 173,000 45,277 13,592 10,399 242,268 Total $ 375,868 $ 102,651 $ 55,848 $ 33,861 $ 568,228 Three Months Ended March 31, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 344,705 $ 100,337 $ 50,701 $ 30,224 $ 525,967 Footwear 67,519 32,522 20,647 7,953 128,641 Total $ 412,224 $ 132,859 $ 71,348 $ 38,177 $ 654,608 Sales channel net sales Wholesale $ 208,569 $ 70,978 $ 56,369 $ 27,242 $ 363,158 Direct-to-consumer 203,655 61,881 14,979 10,935 291,450 Total $ 412,224 $ 132,859 $ 71,348 $ 38,177 $ 654,608 Performance Obligations For the three months ended March 31, 2020 and 2019, Net sales recognized from performance obligations related to prior periods were not material. Net sales expected to be recognized in any future period related to remaining performance obligations is not material. Contract Balances As of March 31, 2020, December 31, 2019 and March 31, 2019, contract liabilities included in Accrued liabilities on the Condensed Consolidated Balance Sheets, which consisted of obligations associated with the Company's gift card and customer loyalty programs, were not material.

Intangible Assets, Net

Intangible Assets, Net	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible assets, net consisted of the following: (in thousands) March 31, December 31, March 31, Intangible assets subject to amortization: Patents and purchased technology $ 14,198 $ 14,198 $ 14,198 Customer relationships 23,000 23,000 23,000 Gross carrying amount 37,198 37,198 37,198 Accumulated amortization: Patents and purchased technology (13,644) (13,311) (12,314) Customer relationships (16,125) (15,713) (14,475) Total accumulated amortization (29,769) (29,024) (26,789) Net carrying amount 7,429 8,174 10,409 Intangible assets not subject to amortization 115,421 115,421 115,421 Intangible assets, net $ 122,850 $ 123,595 $ 125,830 Amortization expense for intangible assets subject to amortization was $0.7 million for each of the three months ended March 31, 2020 and 2019. Annual amortization expense is estimated to be as follows for the years 2020 through 2024: (in thousands) 2020 $ 2,537 2021 1,650 2022 1,650 2023 1,650 2024 688

Short Term Borrowings and Credi

Short Term Borrowings and Credit Lines	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Short-term Debt [Text Block]	NOTE 4—SHORT-TERM BORROWINGS AND CREDIT LINES Except as disclosed below, there have been no significant changes to the Company's short-term borrowing and credit lines as described in Note 9 in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The Company had an unsecured, committed revolving line of credit agreement, maturing on August 1, 2023 with monthly variable commitments available for funding that averaged $50.0 million over the course of a calendar year. Effective March 27, 2020, the Company entered into a first amendment to its unsecured, committed revolving line of credit agreement to increase the commitment available for funding to $125.0 million through December 31, 2020, removing monthly variability in commitment level. Under the first amendment interest, payable monthly, is based on the Company’s applicable funded debt ratio and could range from USD LIBOR plus 200.0 basis points to USD LIBOR plus 275.0 basis points. The first amendment continues to require the Company to comply with certain financial covenants, including a funded debt ratio and interest coverage ratio. If the Company is in default, it is prohibited from paying dividends or repurchasing common stock. At March 31, 2020 the Company was in compliance with all associated covenants. As of March 31, 2020, the outstanding balance under this line of credit was $125.0 million, which was accruing interest at a rate of 3.06% per annum. As disclosed in Note 15, in April 2020, the Company amended and restated this committed revolving line of credit agreement. The Company’s Canadian subsidiary has available an unsecured and uncommitted line of credit, which is payable on demand, guaranteed by the Company, and provides for borrowings up to a maximum of CAD$30.0 million (approximately US$21.2 million) at March 31, 2020. The revolving line accrues interest at the Canadian Prime rate for CAD overdraft borrowings or Bankers' Acceptance rate plus 150 basis points for Bankers' Acceptance loans. As of March 31, 2020, the outstanding balance under this line of credit was CAD$28.4 million (approximately US$20.0 million), which was accruing interest at a rate of 2.89% per annum. The Company’s Japanese subsidiary has two separate unsecured and uncommitted overdraft facilities guaranteed by the Company providing for borrowing up to a maximum of US$7.0 million and ¥300.0 million, respectively (combined approximately US$9.8 million) at March 31, 2020. Borrowings under these overdraft facilities accrue interest at 275.0 basis points and the Tokyo Interbank Offered Rate plus 0.50 basis points, respectively. As of March 31, 2020, the outstanding balances under these facilities were US$6.5 million and ¥300.0 million (approximately US$2.8 million), respectively, which were accruing interest at a rate of 2.75% per annum and 0.55% per annum, respectively. The Company’s Korea subsidiary has available an unsecured and uncommitted overdraft facility guaranteed by the Company providing for borrowing up to a maximum of US$20.0 million at March 31, 2020. Borrowings under the overdraft facility accrue interest at the Korea three month CD rate plus 275.0 basis points. As of March 31, 2020, the outstanding balance under this overdraft facility was US$18.8 million, which was accruing interest at a rate of 4.17% per annum. The Company’s Chinese subsidiary has available an unsecured and uncommitted overdraft and clean advance facility guaranteed by the Company providing for borrowings of advances or overdrafts up to a maximum of US$20.0 million at March 31, 2020. Borrowings under the facility accrue interest on advances of RMB based on the People’s Bank of China (“PBOC”) base rate plus 0.85%, advances of USD based on LIBOR plus 1.8% per annum or overdrafts of RMB based on 110% of the PBOC rate. As of March 31, 2020, the outstanding balance under this facility was RMB9.5 million (approximately US$1.3 million), which was accruing interest based on the PBOC rate plus 0.85% or 5.20% per annum.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	For the three months ended March 31, 2020 and 2019, the Company's effective income tax rates were 86.4% and 19.2%, respectively. The effective income tax rate for the three months ended March 31, 2020 was impacted primarily by the change in mix of book income or loss among jurisdictions, a revaluation of the valuation allowance against deferred tax assets for a foreign operating loss carryforward, and rate arbitrage between the current year expected taxable net operating loss and the tax rate in the year the carryback would offset. Income tax expense, deferred tax assets and related liabilities are based on estimates. The likelihood of realizing the benefits of the deferred tax assets was assessed as of March 31, 2020 and a $1.5 million valuation allowance adjustment was recorded related the expected portion of tax benefits that would not be realized in certain foreign jurisdictions based on available evidence. The Company will continue to monitor the realizability of deferred tax assets, particularly in certain foreign jurisdictions where the COVID-19 pandemic has started to create significant net operating losses. The ability to recover these deferred tax assets depends on several factors, including results of operations and the ability to project future taxable income in those jurisdictions. If it is determined that some additional portion of the tax benefits will not be realized, valuation allowance would be recorded, which would increase income tax expense. Total deferred tax assets as of March 31, 2020 were approximately $73.8 million, of which approximately $14.8 million related to foreign jurisdictions where the Company expects to incur significant net operating losses in the near term, although the risks of failing to realize these benefits vary across jurisdictions.

Product Warranty

Product Warranty	3 Months Ended
	Mar. 31, 2020
Product Warranties Disclosures [Abstract]
Product Warranty	Some of the Company's products carry life-time or limited warranty provisions for defects in quality and workmanship. A warranty reserve is established at the time of sale to cover estimated costs based on the Company's history of warranty repairs and replacements and is recorded in Cost of sales in the Condensed Consolidated Statements of Operations. The warranty reserve is included in Accrued liabilities in the Condensed Consolidated Balance Sheets. A reconciliation of product warranties is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Balance at beginning of period $ 14,466 $ 13,186 Provision for warranty claims 312 1,791 Warranty claims (1,368) (1,723) Other (288) (76) Balance at end of period $ 13,122 $ 13,178

Commitments And Contingencies

Commitments And Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	The Company is a party to various legal claims, actions and complaints from time to time. Although the ultimate resolution of legal proceedings cannot be predicted with certainty, management believes that disposition of these matters will not have a material adverse effect on the Company's condensed consolidated financial statements.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Since the inception of the Company's stock repurchase plan in 2004 through March 31, 2020, the Company's Board of Directors has authorized the purchase of $1.1 billion of the Company's common stock. As of March 31, 2020, the Company had repurchased 26.8 million shares under this program at an aggregate purchase price of $1,017.8 million. Shares repurchased generally settle subsequent to the trade date. During the three months ended March 31, 2020, the Company repurchased an aggregate of $132.9 million of common stock under the stock repurchase plan authorized by the Company's Board of Directors and a pre-established written trading plan. Shares of the Company's common stock may be repurchased in the open market or through privately negotiated transactions, subject to market conditions. The repurchase program does not obligate the Company to acquire any specific number of shares or to acquire shares over any specified period of time. In mid-March 2020 to reduce capital outflows and preserve capital, the Company suspended share repurchases and the Company's Board of Directors suspended the quarterly dividend.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	The Company's stock incentive plan allows for grants of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units and other stock-based or cash-based awards. Stock-based compensation expense Stock-based compensation expense consisted of the following: Three Months Ended March 31, (in thousands) 2020 2019 Stock options $ 1,704 $ 1,489 Restricted stock units 1,971 2,726 Total $ 3,675 $ 4,215 Stock Options During the three months ended March 31, 2020, the Company granted a total of 640,219 stock options at a weighted average grant date fair value of $14.36. As of March 31, 2020, unrecognized costs related to outstanding stock options totaled $16.4 million, before any related tax benefit. As of March 31, 2020, unrecognized costs related to stock options are expected to be recognized over a weighted average period of 3.03 years. Restricted Stock Units During the three months ended March 31, 2020, the Company granted 201,349 restricted stock units at an estimated average grant date fair value of $79.51. As of March 31, 2020, unrecognized costs related to outstanding restricted stock units totaled $27.3 million, before any related tax benefit. As of March 31, 2020, unrecognized costs related to restricted stock units are expected to be recognized over a weighted average period of 2.81 years.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per share ("EPS") is presented on both a basic and diluted basis. Basic EPS is based on the weighted average number of common shares outstanding. Diluted EPS reflects the potential dilution that could occur if outstanding securities or other contracts to issue common stock were exercised or converted into common stock. A reconciliation of common shares used in the denominator for computing basic and diluted EPS is as follows: Three Months Ended March 31, (in thousands, except per share amounts) 2020 2019 Weighted average shares of common stock outstanding, used in computing basic earnings per share 66,970 68,290 Effect of dilutive stock options and restricted stock units 442 762 Weighted average shares of common stock outstanding, used in computing diluted earnings per share 67,412 69,052 Earnings per share of common stock: Basic $ — $ 1.09 Diluted $ — $ 1.07

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	3 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income	Accumulated other comprehensive loss on the Company's Condensed Consolidated Balance Sheets is net of applicable taxes, and consists of unrealized holding gains and losses on available-for-sale securities, unrealized gains and losses on certain derivative transactions and foreign currency translation adjustments. The following table sets forth the changes in Accumulated other comprehensive loss for the three months ended March 31, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2019 $ (4) $ 9,482 $ (13,903) $ (4,425) Other comprehensive income (loss) before reclassifications — 14,362 (15,074) (712) Amounts reclassified from accumulated other comprehensive loss (1) — (2,837) — (2,837) Net other comprehensive income (loss) income during the period — 11,525 (15,074) (3,549) Balance at March 31, 2020 $ (4) $ 21,007 $ (28,977) $ (7,974) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for three months ended March 31, 2019: (in thousands) Unrealized gains (losses) on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2018 $ (60) $ 11,964 $ (15,967) $ (4,063) Other comprehensive income (loss) before reclassifications 56 3,268 (545) 2,779 Amounts reclassified from accumulated other comprehensive loss (1) — (1,935) — (1,935) Net other comprehensive income (loss) during the period 56 1,333 (545) 844 Purchase of non-controlling interest — (99) — (99) Balance at March 31, 2019 $ (4) $ 13,198 $ (16,512) $ (3,318)

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting, Measurement Disclosures [Abstract]
Segment Information	The Company has four reportable geographic segments: U.S., LAAP, EMEA, and Canada, which are reflective of the Company's internal organization, management and oversight structure. Each geographic segment operates predominantly in one industry: the design, development, marketing, and distribution of outdoor, active and everyday lifestyle apparel, footwear, accessories, and equipment products. Intersegment net sales and intersegment profits, which are recorded at a negotiated mark-up and eliminated in consolidation, are not material. Unallocated corporate expenses consist of expenses incurred by centrally-managed departments, including global information systems, finance, human resources and legal, as well as executive compensation, unallocated benefit program expense, and other miscellaneous costs. The geographic distribution of the Company's Net sales and Income (loss) from operations in the Condensed Consolidated Statements of Operations are summarized in the following table for the three months ended March 31, 2020 and 2019. Three Months Ended March 31, (in thousands) 2020 2019 Net sales to unrelated entities: U.S. $ 375,868 $ 412,224 LAAP 102,651 132,859 EMEA 55,848 71,348 Canada 33,861 38,177 $ 568,228 $ 654,608 Segment income (loss) from operations: U.S. $ 40,032 $ 95,723 LAAP 6,138 26,750 EMEA (66) 9,186 Canada 4,151 6,011 Total segment income from operations 50,255 137,670 Unallocated corporate expenses (52,242) (49,712) Interest income, net 1,813 3,400 Other non-operating income, net 1,738 446 Income before income taxes $ 1,564 $ 91,804 Concentrations No single customer accounted for 10% or more of Accounts receivable, net of allowance on the Condensed Consolidated Balance Sheets as of March 31, 2020 or 2019. The Company had one customer that accounted for 13.9% of Accounts receivable, net of allowance as of December 31, 2019. No single customer accounted for 10% or more of Net sales

Financial Instruments And Risk

Financial Instruments And Risk Management	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedges, Assets [Abstract]
Financial Instruments And Risk Management	In the normal course of business, the Company's financial position, results of operations and cash flows are routinely subject to a variety of risks. These risks include risks associated with financial markets, primarily currency exchange rate risk and, to a lesser extent, interest rate risk and equity market risk. The Company regularly assesses these risks and has established policies and business practices designed to mitigate them. The Company does not engage in speculative trading in any financial market. The Company actively manages the risk of changes in functional currency equivalent cash flows resulting from anticipated non-functional currency denominated purchases and sales. Subsidiaries that use European euros, Canadian dollars, Japanese yen, Chinese renminbi, or Korean won as their functional currency are primarily exposed to changes in functional currency equivalent cash flows from anticipated United States dollar inventory purchases. Subsidiaries that use United States dollars and euros as their functional currency also have non-functional currency denominated sales for which the Company hedges the Canadian dollar and Great British pound. The Company manages these risks by using currency forward contracts formally designated and effective as cash flow hedges. Hedge effectiveness is generally determined by evaluating the ability of a hedging instrument's cumulative change in fair value to offset the cumulative change in the present value of expected cash flows on the underlying exposures. For forward contracts, prior to June 2019, the time value components ("forward points") were excluded from the determination of hedge effectiveness and included in current period Cost of sales for hedges of anticipated United States dollar inventory purchases and in Net sales for hedges of anticipated non-functional currency denominated sales on a straight-line basis over the life of the contract. Effective June 2019, the forward points are included in the fair value of the cash flow hedge on a prospective basis. These costs or benefits will be included in Accumulated other comprehensive loss until the underlying hedge transaction is recognized in either Net sales or Cost of sales , at which time, the forward points will also be recognized as a component of Net income . The Company also uses currency forward contracts not formally designated as hedges to manage the consolidated currency exchange rate risk associated with the remeasurement of non-functional currency denominated monetary assets and liabilities by subsidiaries that use United States dollars, euros, Canadian dollars, yen, won, or renminbi as their functional currency. Non-functional currency denominated monetary assets and liabilities consist primarily of cash and cash equivalents, short-term investments, receivables, payables, deferred income taxes, and intercompany loans. The gains and losses generated on these currency forward contracts not formally designated as hedges are expected to be largely offset in Other non-operating income by the gains and losses generated from the remeasurement of the non-functional currency denominated monetary assets and liabilities. The following table presents the gross notional amount of outstanding derivative instruments: (in thousands) March 31, December 31, March 31, Derivative instruments designated as cash flow hedges: Currency forward contracts $ 458,823 $ 471,822 $ 399,068 Derivative instruments not designated as cash flow hedges: Currency forward contracts 205,030 214,086 208,941 At March 31, 2020, $16.8 million of deferred net gains on both outstanding and matured derivatives recorded in Other comprehensive loss are expected to be reclassified to Net income during the next twelve months as a result of underlying hedged transactions also being recorded in Net sales or Cost of sales in the Condensed Consolidated Statements of Operations. Actual amounts ultimately reclassified to Net sales or Cost of sales in the Condensed Consolidated Statements of Comprehensive Income are dependent on United States dollar exchange rates in effect against the euro, pound sterling, renminbi, Canadian dollar, and yen when outstanding derivative contracts mature. At March 31, 2020, the Company's derivative contracts had a remaining maturity of less than four years. The maximum net exposure to any single counterparty, which is generally limited to the aggregate unrealized gain of all contracts with that counterparty, was less than $9.5 million at March 31, 2020. All of the Company's derivative counterparties have credit ratings that are investment grade or higher. The Company is a party to master netting arrangements that contain features that allow counterparties to net settle amounts arising from multiple separate derivative transactions or net settle amounts arising from multiple separate derivative transactions or net settle in the case of certain triggering events such as a bankruptcy or major default of one of the counterparties to the transaction. The Company has not pledged assets or posted collateral as a requirement for entering into or maintaining derivative positions. The following table presents the balance sheet classification and fair value of derivative instruments: (in thousands) Balance Sheet Classification March 31, December 31, March 31, Derivative instruments designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets $ 18,945 $ 11,855 $ 14,366 Currency forward contracts Other non-current assets 10,520 4,159 10,014 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 231 1,313 149 Currency forward contracts Other long-term liabilities — 768 — Derivative instruments not designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets 4,449 2,146 971 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 978 953 349 The following table presents the statement of operations effect and classification of derivative instruments: Statement of Three Months Ended March 31, (in thousands) 2020 2019 Currency Forward and Option Contracts: Derivative instruments designated as cash flow hedges: Gain recognized in other comprehensive income (loss), net of tax — $ 14,362 $ 3,268 Gain (loss) reclassified from accumulated other comprehensive income or loss to income for the effective portion Net sales (122) 35 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Cost of sales 2,795 1,196 Gain reclassified from accumulated other comprehensive income or loss to income as a result of cash flow hedge discontinuance Other non-operating income 1,111 — Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion Net sales — (5) Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion Cost of sales — 1,449 Derivative instruments not designated as cash flow hedges: Gain recognized in income Other non-operating income 1,649 563

Fair Value Measures

Fair Value Measures	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measures	Certain assets and liabilities are reported at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants, under a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows: Level 1 — observable inputs such as quoted prices for identical assets or liabilities in active liquid markets; Level 2 — inputs, other than the quoted market prices in active markets, that are observable, either directly or indirectly; or observable market prices in markets with insufficient volume or infrequent transactions; and Level 3 — unobservable inputs for which there is little or no market data available, that require the reporting entity to develop its own assumptions. The Company's assets and liabilities measured at fair value are categorized as Level 1 or Level 2 instruments. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from inputs, other than quoted market prices in active markets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. Assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 128,488 $ — $ — $ 128,488 United States government treasury bills — 44,973 — 44,973 Available-for-sale short-term investments: (1) United States government treasury bills — 35,032 — 35,032 Other short-term investments: Money market funds 14 — — 14 Mutual fund shares 782 — — 782 Other current assets: Derivative financial instruments — 23,394 — 23,394 Other non-current assets: Money market funds 3,674 — — 3,674 Mutual fund shares 9,329 — — 9,329 Derivative financial instruments — 10,520 — 10,520 Total assets measured at fair value $ 142,287 $ 113,919 $ — $ 256,206 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 1,209 $ — $ 1,209 Total liabilities measured at fair value $ — $ 1,209 $ — $ 1,209 (1) Investments have remaining maturities of less than one year. Assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 288,926 $ — $ — $ 288,926 United States government treasury bills — 34,928 — 34,928 Commercial paper — 33,587 — 33,587 Other short-term investments: Mutual fund shares 1,668 — — 1,668 Other current assets: Derivative financial instruments — 14,001 — 14,001 Non-current assets: Money market funds 1,792 — — 1,792 Mutual fund shares 12,172 — — 12,172 Derivative financial instruments — 4,159 — 4,159 Total assets measured at fair value $ 304,558 $ 86,675 $ — $ 391,233 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,266 $ — $ 2,266 Other long-term liabilities: Derivative financial instruments — 768 — 768 Total liabilities measured at fair value $ — $ 3,034 $ — $ 3,034 Assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 125,073 $ — $ — $ 125,073 Available-for-sale short-term investments: :(1) United States government treasury bills — 270,625 — 270,625 Other short-term investments: Mutual funds shares 1,978 — — 1,978 Other current assets: Derivative financial instruments — 15,337 — 15,337 Other non-current assets: Money market funds 1,331 — — 1,331 Mutual fund shares 9,575 — — 9,575 Derivative financial instruments — 10,014 — 10,014 Total assets measured at fair value $ 137,957 $ 295,976 $ — $ 433,933 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 498 $ — $ 498 Total liabilities measured at fair value $ — $ 498 $ — $ 498 (1) Investments have remaining maturities of less than one year. Non-recurring Fair Value Measurements There were no material assets and liabilities measured at fair value on a nonrecurring basis as of March 31, 2020, December 31, 2019 or March 31, 2019.

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Event	NOTE 15—SUBSEQUENT EVENT On April 15, 2020 the Company entered into a second amended and restated credit agreement (the “restated credit agreement”) which amended and restated the committed revolving line of credit agreement that was in effect as of March 31, 2020 and disclosed in Note 4. The restated credit agreement provides for i) a secured, committed revolving line of credit, maturing on August 1, 2023 with a commitment available for funding of $125.0 million (the "Revolving A Loan"), ii) a secured, committed revolving line of credit, maturing April 13, 2021, with a commitment available for funding of $400.0 million (the "Revolving B Loan", together with the Revolving A Loan, the "Revolving Loans"), and iii) an uncommitted $100.0 million incremental facility, which may be added to the Revolving B Loan if it is executed on, upon request by us to the administrative agent. Advances under the Revolving Loans can be either LIBOR loans or base rate loans. LIBOR loans bear interest on the outstanding principal amount thereof for each interest period at a rate per annum equal to LIBOR (subject to a LIBOR floor of 0.75% for advances under the Revolving A Loan and a LIBOR floor of 1.00% for advances under the Revolving B Loan) plus a margin ranging from 2.00% to 2.75% (the "LIBOR Margin"). Base rate loans bear interest on the outstanding principal amount thereof at a rate per annum equal to the LIBOR Margin plus the greater of (i) daily reset one month LIBOR or (ii) in the case of Revolving A Loans, 0.75% and in the case of Revolving B Loans, 1.00%; provided that if the lenders are unable to price loans based on LIBOR, base rate loans will bear interest at an interest rate per annum equal to a margin ranging from 1% to 1.75% plus the higher of (A) the rate of interest most recently announced by the administrative agent as its prime rate or (B) the federal funds rate plus 1.50%. The restated credit agreement requires the Company to comply with certain financial covenants, including a funded debt ratio, interest coverage ratio, and asset coverage ratio. The obligations of the Company under the restated credit agreement are secured by all assets of the Company and Columbia Brands USA, LLC, except for intellectual property, real property, equity interests in foreign subsidiaries and certain other exclusions. If the Company is in default, it is required to comply with certain restrictions on dividend payments and stock repurchases. On April 15, 2020, the Company borrowed $200 million under the Revolving B Loan, which supplemented $125 million that the Company had previously borrowed under the Revolving A Loan. Those amounts have been subsequently repaid and, at the time of this filing, there is no outstanding balance under the restated credit agreement. Except for the Company's Japanese subsidiary's overdraft facility with a maximum borrowing of ¥300.0 million (approximately US$2.8 million), amounts outstanding under the Company's international subsidiaries' lines of credit and overdraft facilities as of March 31, 2020 have been subsequently repaid.

Basis Of Presentation And Org_2

Basis Of Presentation And Organization Estimates and Assumptions (Policies)	3 Months Ended
	Mar. 31, 2020
Text Block [Abstract]
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of Columbia Sportswear Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Estimates and Assumptions	Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates and assumptions. Some of the more significant estimates relate to revenue recognition, allowance for uncollectible accounts receivable, excess, close-out and slow moving inventory, product warranty, impairment of long-lived assets, intangible assets and goodwill, income taxes, and stock-based compensation. A novel strain of coronavirus ("COVID-19") was first identified in China in December 2019 and a global pandemic of respiratory disease caused by COVID-19 was declared by the World Health Organization in March 2020. As of March 31, 2020, in response to this pandemic, many governments worldwide had implemented travel restrictions, business shutdowns or slowdowns, and shelter-in-place or stay-at-home orders. In first quarter 2020, lower consumer demand related to the COVID-19 pandemic began to impact the Company's financial performance in China in late January, Korea and Japan in early February and North America and Europe in March. Retail traffic trends declined across North America and Europe in early March, prior to store closures which began in mid-March. As of the date of this filing, certain regional and local governments have lifted restrictions and orders. The current environment of uncertainty significantly affected the March 31, 2020 estimates for allowance for uncollectible accounts receivable and excess, close-out and slow-moving inventory. These estimates involve assumptions about future events. The allowance for uncollectible accounts receivable includes assumptions about the future financial condition of our customers and their ability to make required payments. The provision for excess, close-out and slow moving inventory includes assumptions about future demand for the Company’s products and the Company's ability to sell them at a profit. As a result of lower consumer demand related to the COVID-19 pandemic, we tested certain retail locations and their respective lease right-of-use assets for impairment. While no significant impairments were identified, further declines in projected future performance or significant declines in market rents for retail spaces may adversely affect the recovery of these retail locations assets. Additionally, as a result of the COVID-19 pandemic and a significant decline in projected net sales, the prAna brand's trademark and goodwill were tested for impairment as of March 31, 2020. While no impairment was indicated during the first quarter 2020 tests, the degree by which the fair value of the prAna reporting unit and trademark exceeded their respective carrying values declined from our 2019 impairment test. If, due to the current level of uncertainty relating to the COVID-19 pandemic, the prAna brand's actual or projected future performance deteriorates from the projections considered in our first quarter 2020 impairment tests, it is possible that an impairment charge would be required.
Recently Adopted Accounting Pronouncements and Not Yet Adopted	Recently Adopted Accounting Pronouncements Effective January 1, 2020, the Company adopted Accounting Standards Update ("ASU") No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) issued by the Financial Accounting Standards Board ("FASB") in August 2018, which clarifies certain aspects of accounting for implementation costs incurred in a cloud computing arrangement ("CCA") that is a service contract. Under the ASU, an entity would expense costs incurred in the preliminary-project and post-implementation-operation stages. The entity would also capitalize certain costs incurred during the application-development stage, as well as certain costs related to enhancements. The ASU does not change the accounting for the service component of a CCA. The Company adopted the standard using the prospective method and anticipates an increase in cloud-specific implementation assets as specific cloud initiatives are executed by the Company. These assets will generally be included in Other non-current assets in the Condensed Consolidated Balance Sheets and will amortize over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. Upon the adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. Effective January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment issued by the FASB in January 2017, which simplifies the accounting for goodwill impairments by eliminating step two from the goodwill impairment test. Under this guidance, if the carrying amount of a reporting unit exceeds its estimated fair value, an impairment charge shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The impact of the new standard will depend on the specific facts and circumstances of future individual goodwill impairments, if any. Effective January 1, 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments issued by the FASB in June 2016, as well as the clarifying amendments subsequently issued. The pronouncement changes the impairment model for most financial assets and will require the use of an "expected loss" model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Upon adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. On an ongoing basis, the Company will contemplate forward-looking economic conditions in recording lifetime expected credit losses for the Company’s financial assets measured at cost, such as the Company’s trade receivables and certain short-term investments. The following significant accounting policy has been updated since the Company’s 2019 Annual Report on Form 10-K as a result of adoption of ASU No.2016-13: Accounts Receivable Accounts receivable have been reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability of the Company's customers to make required payments. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations. Write-off activity and recoveries for the periods presented were not material. Recent Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU No. 2019-12 ,

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following tables disaggregate the Company's operating segment Net sales by product category and sales channel, which the Company believes provide a meaningful depiction of how the nature, timing, and uncertainty of Net sales are affected by economic factors: Three Months Ended March 31, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 309,677 $ 75,913 $ 39,930 $ 26,649 $ 452,169 Footwear 66,191 26,738 15,918 7,212 116,059 Total $ 375,868 $ 102,651 $ 55,848 $ 33,861 $ 568,228 Sales channel net sales Wholesale $ 202,868 $ 57,374 $ 42,256 $ 23,462 $ 325,960 Direct-to-consumer 173,000 45,277 13,592 10,399 242,268 Total $ 375,868 $ 102,651 $ 55,848 $ 33,861 $ 568,228 Three Months Ended March 31, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 344,705 $ 100,337 $ 50,701 $ 30,224 $ 525,967 Footwear 67,519 32,522 20,647 7,953 128,641 Total $ 412,224 $ 132,859 $ 71,348 $ 38,177 $ 654,608 Sales channel net sales Wholesale $ 208,569 $ 70,978 $ 56,369 $ 27,242 $ 363,158 Direct-to-consumer 203,655 61,881 14,979 10,935 291,450 Total $ 412,224 $ 132,859 $ 71,348 $ 38,177 $ 654,608

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary Of Identifiable Intangible Assets	Intangible assets, net consisted of the following: (in thousands) March 31, December 31, March 31, Intangible assets subject to amortization: Patents and purchased technology $ 14,198 $ 14,198 $ 14,198 Customer relationships 23,000 23,000 23,000 Gross carrying amount 37,198 37,198 37,198 Accumulated amortization: Patents and purchased technology (13,644) (13,311) (12,314) Customer relationships (16,125) (15,713) (14,475) Total accumulated amortization (29,769) (29,024) (26,789) Net carrying amount 7,429 8,174 10,409 Intangible assets not subject to amortization 115,421 115,421 115,421 Intangible assets, net $ 122,850 $ 123,595 $ 125,830
Schedule of finite lived intangible assets future amortization expense	Annual amortization expense is estimated to be as follows for the years 2020 through 2024: (in thousands) 2020 $ 2,537 2021 1,650 2022 1,650 2023 1,650 2024 688

Product Warranty (Tables)

Product Warranty (Tables)	3 Months Ended
	Mar. 31, 2020
Product Warranties Disclosures [Abstract]
Reconciliation Of Product Warranties	A reconciliation of product warranties is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Balance at beginning of period $ 14,466 $ 13,186 Provision for warranty claims 312 1,791 Warranty claims (1,368) (1,723) Other (288) (76) Balance at end of period $ 13,122 $ 13,178

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Stock-based compensation expense consisted of the following: Three Months Ended March 31, (in thousands) 2020 2019 Stock options $ 1,704 $ 1,489 Restricted stock units 1,971 2,726 Total $ 3,675 $ 4,215 Stock Options During the three months ended March 31, 2020, the Company granted a total of 640,219 stock options at a weighted average grant date fair value of $14.36. As of March 31, 2020, unrecognized costs related to outstanding stock options totaled $16.4 million, before any related tax benefit. As of March 31, 2020, unrecognized costs related to stock options are expected to be recognized over a weighted average period of 3.03 years. Restricted Stock Units During the three months ended March 31, 2020, the Company granted 201,349 restricted stock units at an estimated average grant date fair value of $79.51. As of March 31, 2020, unrecognized costs related to outstanding restricted stock units totaled $27.3 million, before any related tax benefit. As of March 31, 2020, unrecognized costs related to restricted stock units are expected to be recognized over a weighted average period of 2.81 years.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Reconciliation Of Common Shares Used In Denominator For Computing Basic And Diluted EPS	A reconciliation of common shares used in the denominator for computing basic and diluted EPS is as follows: Three Months Ended March 31, (in thousands, except per share amounts) 2020 2019 Weighted average shares of common stock outstanding, used in computing basic earnings per share 66,970 68,290 Effect of dilutive stock options and restricted stock units 442 762 Weighted average shares of common stock outstanding, used in computing diluted earnings per share 67,412 69,052 Earnings per share of common stock: Basic $ — $ 1.09 Diluted $ — $ 1.07

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	3 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income, Net Of Related Tax Effects	The following table sets forth the changes in Accumulated other comprehensive loss for the three months ended March 31, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2019 $ (4) $ 9,482 $ (13,903) $ (4,425) Other comprehensive income (loss) before reclassifications — 14,362 (15,074) (712) Amounts reclassified from accumulated other comprehensive loss (1) — (2,837) — (2,837) Net other comprehensive income (loss) income during the period — 11,525 (15,074) (3,549) Balance at March 31, 2020 $ (4) $ 21,007 $ (28,977) $ (7,974) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for three months ended March 31, 2019: (in thousands) Unrealized gains (losses) on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2018 $ (60) $ 11,964 $ (15,967) $ (4,063) Other comprehensive income (loss) before reclassifications 56 3,268 (545) 2,779 Amounts reclassified from accumulated other comprehensive loss (1) — (1,935) — (1,935) Net other comprehensive income (loss) during the period 56 1,333 (545) 844 Purchase of non-controlling interest — (99) — (99) Balance at March 31, 2019 $ (4) $ 13,198 $ (16,512) $ (3,318)

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting, Measurement Disclosures [Abstract]
Schedule Of Segment Information	The geographic distribution of the Company's Net sales and Income (loss) from operations in the Condensed Consolidated Statements of Operations are summarized in the following table for the three months ended March 31, 2020 and 2019. Three Months Ended March 31, (in thousands) 2020 2019 Net sales to unrelated entities: U.S. $ 375,868 $ 412,224 LAAP 102,651 132,859 EMEA 55,848 71,348 Canada 33,861 38,177 $ 568,228 $ 654,608 Segment income (loss) from operations: U.S. $ 40,032 $ 95,723 LAAP 6,138 26,750 EMEA (66) 9,186 Canada 4,151 6,011 Total segment income from operations 50,255 137,670 Unallocated corporate expenses (52,242) (49,712) Interest income, net 1,813 3,400 Other non-operating income, net 1,738 446 Income before income taxes $ 1,564 $ 91,804

Financial Instruments And Ris_2

Financial Instruments And Risk Management (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedges, Assets [Abstract]
Gross Notional Amount Of Outstanding Derivative Instruments	The following table presents the gross notional amount of outstanding derivative instruments: (in thousands) March 31, December 31, March 31, Derivative instruments designated as cash flow hedges: Currency forward contracts $ 458,823 $ 471,822 $ 399,068 Derivative instruments not designated as cash flow hedges: Currency forward contracts 205,030 214,086 208,941
Balance Sheet Classification And Fair Value Of Derivative Instruments	The following table presents the balance sheet classification and fair value of derivative instruments: (in thousands) Balance Sheet Classification March 31, December 31, March 31, Derivative instruments designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets $ 18,945 $ 11,855 $ 14,366 Currency forward contracts Other non-current assets 10,520 4,159 10,014 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 231 1,313 149 Currency forward contracts Other long-term liabilities — 768 — Derivative instruments not designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets 4,449 2,146 971 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 978 953 349 The following table presents the statement of operations effect and classification of derivative instruments: Statement of Three Months Ended March 31, (in thousands) 2020 2019 Currency Forward and Option Contracts: Derivative instruments designated as cash flow hedges: Gain recognized in other comprehensive income (loss), net of tax — $ 14,362 $ 3,268 Gain (loss) reclassified from accumulated other comprehensive income or loss to income for the effective portion Net sales (122) 35 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Cost of sales 2,795 1,196 Gain reclassified from accumulated other comprehensive income or loss to income as a result of cash flow hedge discontinuance Other non-operating income 1,111 — Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion Net sales — (5) Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion Cost of sales — 1,449 Derivative instruments not designated as cash flow hedges: Gain recognized in income Other non-operating income 1,649 563

Fair Value Measures (Tables)

Fair Value Measures (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Assets And Liabilities Measured At Fair Value On A Recurring Basis	Assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 128,488 $ — $ — $ 128,488 United States government treasury bills — 44,973 — 44,973 Available-for-sale short-term investments: (1) United States government treasury bills — 35,032 — 35,032 Other short-term investments: Money market funds 14 — — 14 Mutual fund shares 782 — — 782 Other current assets: Derivative financial instruments — 23,394 — 23,394 Other non-current assets: Money market funds 3,674 — — 3,674 Mutual fund shares 9,329 — — 9,329 Derivative financial instruments — 10,520 — 10,520 Total assets measured at fair value $ 142,287 $ 113,919 $ — $ 256,206 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 1,209 $ — $ 1,209 Total liabilities measured at fair value $ — $ 1,209 $ — $ 1,209 (1) Investments have remaining maturities of less than one year. Assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 288,926 $ — $ — $ 288,926 United States government treasury bills — 34,928 — 34,928 Commercial paper — 33,587 — 33,587 Other short-term investments: Mutual fund shares 1,668 — — 1,668 Other current assets: Derivative financial instruments — 14,001 — 14,001 Non-current assets: Money market funds 1,792 — — 1,792 Mutual fund shares 12,172 — — 12,172 Derivative financial instruments — 4,159 — 4,159 Total assets measured at fair value $ 304,558 $ 86,675 $ — $ 391,233 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,266 $ — $ 2,266 Other long-term liabilities: Derivative financial instruments — 768 — 768 Total liabilities measured at fair value $ — $ 3,034 $ — $ 3,034 Assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 125,073 $ — $ — $ 125,073 Available-for-sale short-term investments: :(1) United States government treasury bills — 270,625 — 270,625 Other short-term investments: Mutual funds shares 1,978 — — 1,978 Other current assets: Derivative financial instruments — 15,337 — 15,337 Other non-current assets: Money market funds 1,331 — — 1,331 Mutual fund shares 9,575 — — 9,575 Derivative financial instruments — 10,014 — 10,014 Total assets measured at fair value $ 137,957 $ 295,976 $ — $ 433,933 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 498 $ — $ 498 Total liabilities measured at fair value $ — $ 498 $ — $ 498

Revenues (Details)

Revenues (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)GeographicSegments	Mar. 31, 2019USD ($)
Disaggregation of Revenue [Line Items]
Number of Operating Segments | GeographicSegments	4
Revenue	$ 568,228	$ 654,608
Wholesale
Disaggregation of Revenue [Line Items]
Revenue	325,960	363,158
Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	242,268	291,450
U.S.
Disaggregation of Revenue [Line Items]
Revenue	375,868	412,224
U.S. | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	202,868	208,569
U.S. | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	173,000	203,655
LAAP
Disaggregation of Revenue [Line Items]
Revenue	102,651	132,859
LAAP | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	57,374	70,978
LAAP | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	45,277	61,881
EMEA
Disaggregation of Revenue [Line Items]
Revenue	55,848	71,348
EMEA | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	42,256	56,369
EMEA | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	13,592	14,979
Canada
Disaggregation of Revenue [Line Items]
Revenue	33,861	38,177
Canada | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	23,462	27,242
Canada | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	10,399	10,935
Apparel, Accessories and Equipment
Disaggregation of Revenue [Line Items]
Revenue	452,169	525,967
Apparel, Accessories and Equipment | U.S.
Disaggregation of Revenue [Line Items]
Revenue	309,677	344,705
Apparel, Accessories and Equipment | LAAP
Disaggregation of Revenue [Line Items]
Revenue	75,913	100,337
Apparel, Accessories and Equipment | EMEA
Disaggregation of Revenue [Line Items]
Revenue	39,930	50,701
Apparel, Accessories and Equipment | Canada
Disaggregation of Revenue [Line Items]
Revenue	26,649	30,224
Footwear
Disaggregation of Revenue [Line Items]
Revenue	116,059	128,641
Footwear | U.S.
Disaggregation of Revenue [Line Items]
Revenue	66,191	67,519
Footwear | LAAP
Disaggregation of Revenue [Line Items]
Revenue	26,738	32,522
Footwear | EMEA
Disaggregation of Revenue [Line Items]
Revenue	15,918	20,647
Footwear | Canada
Disaggregation of Revenue [Line Items]
Revenue	$ 7,212	$ 7,953

Intangible Assets, Net (Summary

Intangible Assets, Net (Summary Of Identifiable Intangible Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	$ 37,198	$ 37,198	$ 37,198
Intangible assets subject to amortization, Accumulated amortization	(29,769)	(29,024)	(26,789)
Intangible assets subject to amortization, Net carrying amount	7,429	8,174	10,409
Intangible assets not subject to amortization	115,421	115,421	115,421
Intangible assets, net	122,850	123,595	125,830
Patents And Purchased Technology [Member]
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	14,198	14,198	14,198
Intangible assets subject to amortization, Accumulated amortization	(13,644)	(13,311)	(12,314)
Customer Relationships [Member]
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	23,000	23,000	23,000
Intangible assets subject to amortization, Accumulated amortization	$ (16,125)	$ (15,713)	$ (14,475)

Intangible Assets, Net (Details

Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 0.7	$ 0.7

Intangible Assets, Net and Good

Intangible Assets, Net and Goodwill Schedule of Estimated Five Year Amortization Expense (Details) $ in Thousands	Mar. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 2,537
2021	1,650
2022	1,650
2023	1,650
2024	$ 688

Short Term Borrowings and Cre_2

Short Term Borrowings and Credit Lines (Details) ¥ in Millions, $ in Millions, $ in Millions	Mar. 31, 2020CAD ($)	Mar. 31, 2020JPY (¥)	Mar. 31, 2020USD ($)
Debt Instrument [Line Items]
Line of Credit Facility, Interest Rate at Period End	3.06%	3.06%	3.06%
Line of Credit Facility, Remaining Borrowing Capacity			$ 50
Letters of credit outstanding			125
Unsecured And Uncommitted Credit Line1 [Member] | Japanese Subsidiary
Debt Instrument [Line Items]
Maximum borrowing capacity			7
Letters of credit outstanding			6.5
Unsecured And Uncommitted Credit Line2 | Japanese Subsidiary
Debt Instrument [Line Items]
Maximum borrowing capacity | ¥		¥ 300
Letters of credit outstanding | ¥		¥ 300
Unsecured And Uncommitted Line Of Credit | Canadian Subsidiary [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 30		21.2
Letters of credit outstanding	$ 28.4		20
Unsecured And Uncommitted Line Of Credit | Japanese Subsidiary
Debt Instrument [Line Items]
Maximum borrowing capacity			9.8
Letters of credit outstanding			2.8
Unsecured And Uncommitted Line Of Credit | Korean Subsidiary [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity			20
Letters of credit outstanding			18.8
Unsecured And Uncommitted Line Of Credit | China Subsidiary [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity			20
Letters of credit outstanding			$ 1.3

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Income Tax Contingency [Line Items]
Effective Income Tax Rate Percentage Expense (Benefit)	(86.40%)	(19.20%)
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount	$ 1,500
Deferred Income Tax Assets, Net	73,827	$ 77,760	$ 78,849
8888 Foreign Governments [Member]
Income Tax Contingency [Line Items]
Deferred Income Tax Assets, Net	$ 14,800

Product Warranty (Reconciliatio

Product Warranty (Reconciliation Of Product Warranties) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reconciliation of Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 14,466	$ 13,186
Provision for warranty claims	312	1,791
Warranty claims	(1,368)	(1,723)
Other	(288)	(76)
Balance at end of period	$ 13,122	$ 13,178

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Equity [Abstract]
Stock Repurchased During Period, Value	$ 132,889	$ 19,074
Stock Repurchase Program, Authorized Amount	$ 1,100,000
Stock Repurchase Program Number Of Shares Repurchased To Date	26.8
Stock Repurchased To Date Value	$ 1,017,800

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details)	3 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Employee Stock Options [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options granted (in shares) | shares	640,219
Unrecognized costs related to share based compensation | $	$ 16,400,000
Weighted average period of recognition of unrecognized costs related to stock options, years	3 years 10 days
Equity Option [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 14.36
Restricted Stock Units [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 79.51
Unrecognized costs related to share based compensation | $	$ 27,300,000
Weighted average period of recognition of unrecognized costs related to stock options, years	2 years 9 months 21 days
Restricted stock units granted (in shares) | shares	201,349

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary Of Stock-Based Compensation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 3,675	$ 4,215
Employee Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	1,704	1,489
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 1,971	$ 2,726

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule Of Weighted Average Assumptions) (Details)	3 Months Ended
	Mar. 31, 2020$ / shares
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 14.36

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule Of Weighted Average Assumptions For Restricted Stock Units) (Details)	3 Months Ended
	Mar. 31, 2020$ / shares
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 79.51

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share, number of shares	937,523	325,226
Stock Repurchased During Period, Value	$ 132,889	$ 19,074

Earnings Per Share (Reconciliat

Earnings Per Share (Reconciliation Of Common Shares Used In Denominator For Computing Basic And Diluted EPS) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	937,523	325,226
Weighted average shares of common stock outstanding, used in computing basic earnings per share (in shares)	66,970,000	68,290,000
Effect of dilutive stock options and restricted stock units (in shares)	442,000	762,000
Weighted-average shares of common stock outstanding, used in computing diluted earnings per share (in shares)	67,412,000	69,052,000
Income Loss From Continuing Operations Per Basic And Diluted Share [Abstract]
Earnings (loss) per share of common stock, Basic (in dollars per share)	$ 0	$ 1.09
Earnings (loss) per share of common stock, Diluted (in dollars per share)	$ 0	$ 1.07

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	$ (4,425)	$ (4,063)
Other comprehensive income (loss) before reclassifications	(712)	2,779
Amounts reclassified from other comprehensive income	(2,837)	(1,935)
Net other comprehensive income (loss) during the period	(3,549)	844
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests		16,555
Accumulated other comprehensive income (loss) at end of period	(7,974)	(3,318)
Unrealized Gains (Losses) on Available-For-Sale Securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	(4)	(60)
Other comprehensive income (loss) before reclassifications	0	56
Amounts reclassified from other comprehensive income	0	0
Net other comprehensive income (loss) during the period	0	56
Accumulated other comprehensive income (loss) at end of period	(4)	(4)
Unrealized Holding Gains (Losses) on Derivative Transactions [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	9,482	11,964
Other comprehensive income (loss) before reclassifications	14,362	3,268
Amounts reclassified from other comprehensive income	(2,837)	(1,935)
Net other comprehensive income (loss) during the period	11,525	1,333
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	99
Accumulated other comprehensive income (loss) at end of period	21,007	13,198
Foreign Currency Translation Adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	(13,903)	(15,967)
Other comprehensive income (loss) before reclassifications	(15,074)	(545)
Amounts reclassified from other comprehensive income	0	0
Net other comprehensive income (loss) during the period	(15,074)	(545)
Accumulated other comprehensive income (loss) at end of period	(28,977)	(16,512)
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	$ 99	$ 99

Segment Information Concentrati

Segment Information Concentration (Details) - GeographicSegments	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Jun. 30, 2019
Concentration Risk [Line Items]
Number of Operating Segments	4
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		13.90%
Revenue, Product and Service Benchmark [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%

Segment Information (Schedule O

Segment Information (Schedule Of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Income from operations	$ (1,987)	$ 87,958
Interest income, net	1,813	3,400
Other non-operating expense	1,738	446
Income before income tax	1,564	91,804
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	568,228	654,608
Income from operations	50,255	137,670
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Unallocated corporate expenses	(52,242)	(49,712)
United States [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	375,868	412,224
Income from operations	40,032	95,723
LAAP | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	102,651	132,859
Income from operations	6,138	26,750
EMEA [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	55,848	71,348
Income from operations	(66)	9,186
Canada [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	33,861	38,177
Income from operations	$ 4,151	$ 6,011

Financial Instruments And Ris_3

Financial Instruments And Risk Management (Narrative) (Details)	3 Months Ended
	Mar. 31, 2020USD ($)
Derivative [Line Items]
Deferred net gains on derivatives accumulated in other comprehensive income expected reclassification to net income in next twelve months	$ 16,800,000
Derivatives maximum remaining maturity	4 years
Maximum
Derivative [Line Items]
Aggregate unrealized gain of derivative contracts with single counterparty	$ 9,500,000

Financial Instruments And Ris_4

Financial Instruments And Risk Management (Gross Notional Amount Of Outstanding Derivative Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative, Remaining Maturity	4 years
Derivative Instruments Designated As Cash Flow Hedges [Member] | Currency Forward Contracts [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency forward contracts	$ 458,823	$ 471,822	$ 399,068
Derivative Instruments Not Designated As Cash Flow Hedges [Member] | Currency Forward Contracts [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency forward contracts	$ 205,030	$ 214,086	$ 208,941

Financial Instruments And Ris_5

Financial Instruments And Risk Management (Balance Sheet Classification And Fair Value Of Derivative Instruments) (Details) - Currency Forward Contracts [Member] - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Prepaid Expenses And Other Current Assets [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	$ 18,945	$ 11,855	$ 14,366
Prepaid Expenses And Other Current Assets [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	4,449	2,146	971
Other Noncurrent Assets [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	10,520	4,159	10,014
Accrued Liabilities [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	231	1,313	149
Accrued Liabilities [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	978	953	349
Other Long Term Liabilities [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	$ 0	$ 768	$ 0

Financial Instruments And Ris_6

Financial Instruments And Risk Management (Effect And Classification Of Derivative Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in other comprehensive income or loss	$ 14,362	$ 3,268
Cost of Sales [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	2,795	1,196
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	0	1,449
Sales [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	(122)	35
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	0	(5)
Other Non-operating Income (Expense) [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	1,111	0
Gain (loss) recognized in income or loss	$ 1,649	$ 563

Fair Value Measures (Assets And

Fair Value Measures (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 256,206	$ 391,233	$ 433,933
Total liabilities measured at fair value	1,209	3,034	498
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	142,287	304,558	137,957
Total liabilities measured at fair value	0	0	0
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	113,919	86,675	295,976
Total liabilities measured at fair value	1,209	3,034	498
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Total liabilities measured at fair value	0	0	0
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	1,209	2,266	498
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	1,209	2,266	498
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		768
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		768
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Cash Equivalents [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	128,488
Cash Equivalents [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	128,488
Cash Equivalents [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Cash Equivalents [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Cash Equivalents [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	44,973	34,928
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	44,973	34,928
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0
Cash Equivalents [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		33,587
Cash Equivalents [Member] | Commercial Paper [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Cash Equivalents [Member] | Commercial Paper [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		33,587
Cash Equivalents [Member] | Commercial Paper [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Available-For-Sale Short-Term Investments [Member] | Repurchase Agreements [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value			270,625
Available-For-Sale Short-Term Investments [Member] | Repurchase Agreements [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value			0
Available-For-Sale Short-Term Investments [Member] | Repurchase Agreements [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value			270,625
Available-For-Sale Short-Term Investments [Member] | Repurchase Agreements [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value			0
Available-For-Sale Short-Term Investments [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	35,032
Available-For-Sale Short-Term Investments [Member] | US Treasury Securities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Available-For-Sale Short-Term Investments [Member] | US Treasury Securities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	35,032
Available-For-Sale Short-Term Investments [Member] | US Treasury Securities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Cash and Cash Equivalents [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		288,926	125,073
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		288,926	125,073
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0	0
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0	0
Short-term Investments [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	14
Short-term Investments [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	14
Short-term Investments [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Short-term Investments [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Short-term Investments [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	782	1,668	1,978
Short-term Investments [Member] | Mutual Fund [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	782	1,668	1,978
Short-term Investments [Member] | Mutual Fund [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Short-term Investments [Member] | Mutual Fund [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	23,394	14,001	15,337
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	23,394	14,001	15,337
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	3,674	1,792	1,331
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	3,674	1,792	1,331
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	9,329	12,172	9,575
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	9,329	12,172	9,575
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	10,520	4,159	10,014
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	10,520	4,159	10,014
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 0	$ 0	$ 0

Subsequent Event (Details)

Subsequent Event (Details) ¥ in Millions	Apr. 15, 2020USD ($)	Mar. 31, 2020USD ($)	May 07, 2020USD ($)	Mar. 31, 2020JPY (¥)	Mar. 31, 2020USD ($)
Debt Instrument [Line Items]
Letters of credit outstanding					$ 125,000,000
Japanese Subsidiary | Unsecured And Uncommitted Credit Line2
Debt Instrument [Line Items]
Maximum borrowing capacity | ¥				¥ 300
Letters of credit outstanding | ¥				¥ 300
Japanese Subsidiary | Unsecured And Uncommitted Line Of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity					9,800,000
Letters of credit outstanding					$ 2,800,000
Revolving A Loan | Revolving Credit Facility
Debt Instrument [Line Items]
Proceeds from secured lines of credit		$ 125,000,000
Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term line of credit			$ 0
Subsequent Event | Revolving A Loan | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 125,000,000
Subsequent Event | Revolving B Loan | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	400,000,000
Line of credit facility, increase limit	100,000,000
Proceeds from secured lines of credit	$ 200,000,000
London Interbank Offered Rate (LIBOR) | Subsequent Event | Revolving A Loan | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0.75%
London Interbank Offered Rate (LIBOR) | Subsequent Event | Revolving B Loan | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Fed Funds Effective Rate Overnight Index Swap Rate | Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
Minimum | London Interbank Offered Rate (LIBOR) | Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Minimum | Base Rate | Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Maximum | London Interbank Offered Rate (LIBOR) | Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Maximum | Base Rate | Subsequent Event | Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%